Union Savings Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.6K Hold
258
0.01% 223
2026
Q1
$36K Hold
258
0.02% 215
2025
Q4
$31.7K Buy
+258
New +$31.4K 0.01% 225
2025
Q2
$23K Hold
205
0.01% 239
2025
Q1
$23K Hold
205
0.01% 248
2024
Q4
$18.9K Hold
205
0.01% 258
2024
Q3
$17.2K Hold
205
0.01% 261
2024
Q2
$14.1K Sell
205
-170
-45% -$11.3K 0.01% 265
2024
Q1
$27.5K Hold
375
0.01% 242
2023
Q4
$30.4K Hold
375
0.02% 240
2023
Q3
$28.1K Hold
375
0.02% 240
2023
Q2
$28.5K Buy
+375
New +$29.9K 0.02% 233

Other funds holding GILD

Union Savings Bank's GILD Position: Q2 2026 in Review

Union Savings Bank held its Gilead Sciences (GILD) position steady in Q2 2026 at 258 shares worth $32.6K. The position accounts for 0.01% of the portfolio, ranked #223.

Union Savings Bank first reported a position in GILD in Q2 2023 and has held it in 12 quarters since. The position peaked at $36K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Union Savings Bank held 258 shares of Gilead Sciences worth $32.6K as of Q2 2026.
  • Union Savings Bank left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Union Savings Bank's portfolio in Q2 2026, its #223 holding.
  • Union Savings Bank first reported a position in Gilead Sciences in Q2 2023 and has held it in 12 quarters since.
  • Union Savings Bank's Gilead Sciences position peaked at $36K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Union Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.